These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9496387)

  • 1. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP).
    Vanhoefer U; Cao S; Harstrick A; Seeber S; Rustum YM
    Ann Oncol; 1997 Dec; 8(12):1221-8. PubMed ID: 9496387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein.
    Vanhoefer U; Cao S; Minderman H; Tóth K; Scheper RJ; Slovak ML; Rustum YM
    Clin Cancer Res; 1996 Feb; 2(2):369-77. PubMed ID: 9816180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
    Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
    Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in docetaxel and paclitaxel activity in resistant tumor cells which express MRP: need of comparative clinical trials in resistant patients.
    D'Incalci M
    Ann Oncol; 1997 Dec; 8(12):1183-4. PubMed ID: 9496382
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N- nitrosourea associated with inhibition of multidrug resistance protein (MRP) function.
    Vanhoefer U; Yin MB; Harstrick A; Seeber S; Rustum YM
    Biochem Pharmacol; 1997 Mar; 53(6):801-9. PubMed ID: 9113101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines.
    Slovak ML; Ho JP; Bhardwaj G; Kurz EU; Deeley RG; Cole SP
    Cancer Res; 1993 Jul; 53(14):3221-5. PubMed ID: 8391919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor effect of docetaxel against human esophagus tumor cell lines and tumor xenografts in nude mice].
    Shakuto S; Fujita F; Fujita M
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):337-43. PubMed ID: 16531714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere).
    Dykes DJ; Bissery MC; Harrison SD; Waud WR
    Invest New Drugs; 1995; 13(1):1-11. PubMed ID: 7499102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
    Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
    J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.
    Sirotnak FM; Zakowski MF; Miller VA; Scher HI; Kris MG
    Clin Cancer Res; 2000 Dec; 6(12):4885-92. PubMed ID: 11156248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
    Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
    Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models.
    Naito M; Matsuba Y; Sato S; Hirata H; Tsuruo T
    Clin Cancer Res; 2002 Feb; 8(2):582-8. PubMed ID: 11839680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antitumour effects of docetaxel (Taxotere) on human gastric cancers in vitro and in vivo.
    Tanaka M; Obata T; Sasaki T
    Eur J Cancer; 1996 Feb; 32A(2):226-30. PubMed ID: 8664032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice.
    Perez-Soler R; Kemp B; Wu QP; Mao L; Gomez J; Zeleniuch-Jacquotte A; Yee H; Lee JS; Jagirdar J; Ling YH
    Clin Cancer Res; 2000 Dec; 6(12):4932-8. PubMed ID: 11156254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P.
    Chen ZS; Furukawa T; Sumizawa T; Ono K; Ueda K; Seto K; Akiyama SI
    Mol Pharmacol; 1999 May; 55(5):921-8. PubMed ID: 10220571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells.
    Vanhoefer U; Voigt W; Hilger RA; Yin MB; Harstrick A; Seeber S; Rustum YM
    Oncol Res; 1997; 9(9):485-94. PubMed ID: 9495454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance.
    Vredenburg MR; Ojima I; Veith J; Pera P; Kee K; Cabral F; Sharma A; Kanter P; Greco WR; Bernacki RJ
    J Natl Cancer Inst; 2001 Aug; 93(16):1234-45. PubMed ID: 11504769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo.
    Shi B; Yaremko B; Hajian G; Terracina G; Bishop WR; Liu M; Nielsen LL
    Cancer Chemother Pharmacol; 2000; 46(5):387-93. PubMed ID: 11127943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P.
    Sumizawa T; Chen ZS; Chuman Y; Seto K; Furukawa T; Haraguchi M; Tani A; Shudo N; Akiyama SI
    Mol Pharmacol; 1997 Mar; 51(3):399-405. PubMed ID: 9058594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.